about
Genetically modified mouse models for the study of nonalcoholic fatty liver diseaseMechanisms of hepatic fibrogenesisTestosterone replacement ameliorates nonalcoholic fatty liver disease in castrated male ratsAn ErChen and YinChen Decoction Ameliorates High-Fat-Induced Nonalcoholic Steatohepatitis in Rats by Regulating JNK1 Signaling Pathway.Experimental models of non-alcoholic fatty liver disease in rats.Hepatoprotective and antioxidant activities of extracts from Salvia-Nelumbinis naturalis against nonalcoholic steatohepatitis induced by methionine- and choline-deficient diet in mice.Caspase-1 as a central regulator of high fat diet-induced non-alcoholic steatohepatitis.Curcumin limits the fibrogenic evolution of experimental steatohepatitis.NGF and P75NTR gene expression is associated with the hepatic fibrosis stage due to viral and non-viral causes.Modest fructose beverage intake causes liver injury and fat accumulation in marginal copper deficient rats.Rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.Kefir peptides prevent high-fructose corn syrup-induced non-alcoholic fatty liver disease in a murine model by modulation of inflammation and the JAK2 signaling pathway.Altered hepatic lipid metabolism contributes to nonalcoholic fatty liver disease in leptin-deficient Ob/Ob mice.PPARs and nonalcoholic fatty liver disease.Quantification and mechanisms of oleic acid-induced steatosis in HepG2 cells.Evaluation of Nonalcoholic Fatty Liver Disease in C57BL/6J Mice by Using MRI and Histopathologic Analyses.Comparative study of fatty liver induced by methionine and choline-deficiency in C57BL/6N mice originating from three different sources.Effect of physical training on liver expression of activin A and follistatin in a nonalcoholic fatty liver disease model in rats.Characterization of high-fat, diet-induced, non-alcoholic steatohepatitis with fibrosis in ratsβ-glycosphingolipids ameliorated non-alcoholic steatohepatitis in the Psammomys obesus model.Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturaseCardiac evaluation of liver transplant candidatesCaspase-1-mediated regulation of fibrogenesis in diet-induced steatohepatitis.Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.Antigen peptide transporter 1 is involved in the development of fructose-induced hepatic steatosis in mice.The effect of β-caryophyllene on nonalcoholic steatohepatitis.A biomarker panel for non-alcoholic steatohepatitis (NASH) and NASH-related fibrosis.Hyperlipidemic chicken as a model of non-alcoholic steatohepatitis.Testosterone Protects High Fat/Low Carbohydrate Diet Induced Non-Alcoholic Fatty Liver Disease in Castrated Male Rats Mainly via Modulating ER Stress.The hepatoprotective effect of Phyllanthus emblica L. fruit on high fat diet-induced non-alcoholic fatty liver disease (NAFLD) in SD rats.Deficiency in galectin-3 promotes hepatic injury in CDAA diet-induced nonalcoholic fatty liver disease.Drug-induced steatohepatitis
P2860
Q26865248-8032CC31-4781-4040-A69B-55B706BD5B63Q29619336-5E4DE4C2-30E9-4FD1-B4FA-193C7F0CFAB3Q33569603-FDDE216D-52B4-4675-972F-7342E1207C2FQ33819857-15AF8A4A-CE7B-4EE4-9A6B-349BD0E350EDQ33886936-1E51CCCD-029B-4D11-ABE2-4D8D80ECD7AAQ34551170-C21655AF-DFAF-477F-BE96-FFA98B214538Q34586647-D724E9C0-E0EB-4004-B0C1-C7884DA54D23Q34613675-54532C0D-BE7F-460C-9E47-D379D67329CEQ35225194-76F692A6-14A6-425A-BCF7-9892AE9D2BE9Q36961832-90816FAC-A6B6-4418-BABC-21EB703822EBQ37375389-83CDC6E7-852C-423C-A101-8F3A09E2A72AQ37575895-13F2B03A-36AF-4903-BEB9-F2E226E7EE07Q38317751-52B183FB-A4EB-4EC0-99B7-A546A6D0B114Q39029023-8BE8F10D-BEBE-4CB2-87C2-2EF0D965B446Q39208263-49A1912B-F427-4E6E-9BB2-18CB94518660Q40424699-315F28FC-B71C-4AE5-A551-05D049496B8BQ41125952-A54D0C4B-DCA7-4432-BF1E-048200D855B5Q41809848-F689FEC0-F05A-4118-AF99-D0F1368F2B25Q41854395-F1E43001-327A-4AA6-95D1-BEE0DF072001Q42066264-FF3BC42A-6BBE-4338-85B0-FDFFA94D977BQ42563412-AF87BF9C-289E-41C0-A91D-84B91B29BA8FQ42587869-EB927FC2-ABD0-40A1-86EF-6EF02E942D39Q42934583-B28BB0D2-1C29-4200-BABE-6D955694925BQ43174499-FAFEA363-497A-4C17-82A6-720279C40E90Q44665378-02B67628-4EEA-4500-9E16-F99B180FE17AQ45790201-1D590986-3A42-4EC1-AD30-D5B8806E3A4CQ46177222-65812F6C-5247-49C9-B956-A114B3EC507AQ46255944-8EAB7E84-4CAA-4A77-8238-E0C229D3AFA7Q47775932-C1C98FCF-42C9-4740-89B9-CAD0512C75E5Q48304990-696D129B-B7A1-405D-A3A0-E972C2671B9EQ55692292-81422D6F-78B9-4943-A88B-301B45ABBF64Q56541717-8735002A-8F56-4A0C-9EF7-A444DF143F13
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Pathogenesis of NASH: animal models.
@en
type
label
Pathogenesis of NASH: animal models.
@en
prefLabel
Pathogenesis of NASH: animal models.
@en
P1476
Pathogenesis of NASH: animal models.
@en
P2093
Jacob George
Roslyn M London
P304
55-74, viii
P356
10.1016/J.CLD.2007.02.010
P577
2007-02-01T00:00:00Z